OncoSwab

This Thanksgiving, we’re taking a moment to say thank you. To the caregivers who selflessly support loved ones with lung cancer, to the survivors who inspire us with their strength, and to those still fighting - we see you, we root for you, and you’re at the heart of everything we do. To our partners, colleagues, supporters and everyone who believes in OncoSwab: thank you for trusting us to push boundaries and work toward a future where lung cancer is no longer a death sentence. You inspire us to give our all every day, and together, we’re creating a world where more loved ones get the time they deserve. Happy Thanksgiving from all of us at OncoSwab.

Improving Lung Cancer Detection: A Call to Action for Primary Care Physicians Scott Jacobson OncoSwab Nikki Audia https://lnkd.in/eb5C_Bhu #OncoDaily #Oncology #Cancer #Health #Medicine #LungCancer #CancerCare

?? Hacia el futuro del diagnóstico precoz del cáncer de pulmón ?? Nos llena de orgullo compartir que la Fundación Dr. Pérez Pallarés, en colaboración con Instituto Clínico Andreo de #CARTAGENA ha comenzado un innovador estudio junto a OncoSwab para desarrollar una tecnología revolucionaria destinada al diagnóstico temprano del cáncer de pulmón. ?? Este proyecto, único a nivel mundial y que pretende cambiar la historia natural del cáncer de pulmón, reúne a tres instituciones de prestigio internacional: Hospital Universitario Central de Asturias (HUCA) de Espa?a, liderado por el prestigioso neumólogo Miguel Angel Ariza Prota Instituto Clínico Andreo de Espa?a, liderado por nuestro fundador, el neumólogo Javier Pérez Pallarés Inselspital, Universidad de Berna, Suiza, liderado por el Konstantinos Gioutsos ?? La investigación se centra en utilizar tecnologías avanzadas para detectar el cáncer de pulmón en etapas iniciales, marcando un antes y un después en la prevención y tratamiento de esta enfermedad. ?? Este esfuerzo no solo refuerza la importancia de la colaboración internacional en la ciencia, sino también nuestro compromiso con la mejora de la calidad de vida de los pacientes. ?? Juntos estamos escribiendo un capítulo crucial en la lucha contra el cáncer. ?Gracias a todos los que hacen esto posible! #Innovación #DiagnósticoPrecoz #CáncerDePulmón #SaludGlobal #CienciaColaborativa

??1.6 million nodules, 1.6 million moments that matter. Each year, 1.6 million Americans are diagnosed with incidental pulmonary nodules. But here’s the harsh reality: over 60% of these cases are lost to follow-up, leaving patients in limbo and lives at risk. This isn’t just a number, it’s a wake-up call! At Oncoswab, we’re here to make sure those moments don’t slip away. With our non-invasive nasal swabs, we’re aiming at closing these gaps, prioritizing early detection, and ensuring follow-up care stays on track. Because behind every number is a life, and every life deserves a fighting chance. #Lungcancerawarenessmonth #lungcancer #earlydetection

Lung cancer is one of the most common cancers worldwide, yet screening policies haven’t caught up with this reality. Right now, screenings focus almost entirely on people with a history of heavy smoking. But here’s the truth: thousands of people diagnosed with lung cancer every year have never smoked a cigarette in their life. Where does that leave them? ??Left out of critical screenings. ??Misunderstood. ??Invisible in the larger conversation. It’s time to change that. Lung cancer doesn’t follow stereotypes, and our policies shouldn’t either. We need screening guidelines that reflect the full spectrum of risk, greater research, and inclusive policies that give everyone a fighting chance. No one should feel unseen in this fight. Let’s move this conversation forward - because every story deserves a voice! #Lungcancerawarenessmonth #lungcancer #earlydetection

Nothing is more anxiety-inducing than waiting for a potential life-changing diagnosis. Exactly this is what Johannes, an advocate and OncoSwab investor, experienced. A few years ago, after dealing with a persistent cough, Johannes decided to get it checked out, thinking it was nothing serious. However, doctors found a nodule on his lung during a CT scan. This unexpected news was concerning, and the possibility that it could be lung cancer weighed heavily on his mind. He was told he had to wait three months before a biopsy could determine if the nodule was malignant. Those months were challenging, filled with anxiety and uncertainty. He found it difficult to focus on his university studies; lectures and assignments became hard to manage under the stress. Eventually, he stopped studying and put his life on hold. He couldn't find the mental space to continue as usual. When the biopsy results finally came back after three long months as benign, the relief was immense. Johannes felt like he could breathe again. But he also realized how much those months had affected him - missed moments with loved ones, setbacks in his education, and an impact on his mental well-being. During this Lung Cancer Awareness Month, Johannes wants to highlight the need for better resources and support systems for those awaiting important medical results. If you or someone you know is going through something similar, please know that you're not alone. Reach out to friends, family, or support groups. Sharing fears and concerns can make a significant difference. He emphasizes that early detection and quicker diagnostic processes are crucial not just for physical health, but for mental and emotional well-being as well. At OncoSwab, it is exactly because of stories like Johannes's that we are striving to make early detection as accessible and timely as possible to give everyone the certainty they deserve. #Lungcancerawareness #Lungcancer

??? 1 in 5 people diagnosed with lung cancer have never smoked. Lung cancer awareness isn’t just about smokers—it’s about everyone. Whether you’re a smoker or not, cancer doesn’t discriminate. Anyone with lungs can get lung cancer. Now, the question is: what can we do to increase early diagnosis in non-smokers? At OncoSwab, it’s all about non-invasive testing and accessibility. And that’s what we’re striving for. #LungCancerAwareness #LungCancerScreening #CancerScreening #LungCancer

Team work making the dream work! #lungcancer #diagnostics #cancerscreening #lungcancerscreening

Finalists of the Digital Health Nation Innovation Booster powered by Innosuisse met this week in Basel for the last bootcamp of the program, and it was an intense and exciting experience!?This time, the focus was on building clear project roadmaps, aligning with strategic vision, and gearing up for investor readiness. ?? ?? ?? Congratulations to the Top 5 teams on the impressive progress they’ve shown throughout the program: Beyond Diagnostics, ALPINA+SANA, SensApp by OrthoSens, OncoSwab and neuroAIgnostics. Keep pushing boundaries and inspiring change! Special thank you goes to Aurélie Moser ?? for leading the workshop and to all the experts who joined us onsite — your insights were invaluable. ?? Petar Angelov and Moritz W?lchli from Deloitte, Dr. Melanie Steck from BRAUNPAT AG, Christine Jacob ?????? and Steven (Steve) Bourke. Excited to see these innovative projects continue to grow and make an impact in the digital health space. #healthcareinnovation #swissinnovationbooster #digitalhealth Yana Yoncheva | Ursula Costa | DayOne - Healthcare Innovation | Dr. Maren Schinz | Ema Grabenweger | Gwenael Hannema | Oleg Kotsur | Perrine Lhuillier (吕贝琳）| Nicolas Langer | Roberta Gatta, PhD

Congratulations to the Venture Leaders Medtech 2024 on an incredible pitch competition! The ten talented medtech founders on the "Swiss National Startup Team" gathered last night to present their innovations to an audience of Boston-area investors, industry leaders, and experts. After two rounds of voting, the winner was declared: OncoSwab, a Swiss startup developing a non-invasive test to quickly detect early stage lung cancer, represented by co-founder Pablo Lara, PhD. As the winner of this year’s Medtech Pitchfest, OncoSwab will receive a three-month residency at #Swissnex, offering them a unique chance to immerse themselves in the Boston ecosystem. A huge thank you to the Venture Leaders for showcasing their cutting-edge solutions, to Lando & Anastasi, LLP for supporting the event, and to our engaged audience for their support and participation! Venture Leaders Medtech is organized by Venturelab and #Swissnex and supported by EPFL, ETH Zürich, Hansj?rg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard Startup & VC Desk, Etat de Vaud (Innovaud/Vaud Promotion), Kanton Zürich, and VISCHER. Apersys AG Aseptuva BIOS Medical Calico Biosystems Citus Impli Metadvice MYNERVA OneTwenty.ai #VLeadersMedtech #VentureLeaders #SwissStartups #SwissInnovation